A Study to Assess the Safety, Tolerability, Ciliary Rescue, and Pharmacodynamics of RCT1100 in Adults With PCD

Clinical trial NCT06600425 · COMPLETED

Trial details

NCT number: NCT06600425
Sponsor: ReCode Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Ciliary Dyskinesia

Start date: 2024-09-20
Primary completion: 2025-06-06
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.